Seasonal vaccines and sarcoidosis: partial translation
Partial translation of the original Croatian article. This text reflects the original source and has not been clinically updated. Omitted passages are marked below. The Croatian original remains unchanged.
Seasonal vaccines and sarcoidosis
The question is often asked whether a person with sarcoidosis may be vaccinated against influenza or coronavirus. The answers cannot be universal because sarcoidosis, as a multisystem disease that ranges from an acute to a chronic state, varies in its extent and severity.
In general, a person in the acute phase or in remission probably uses first- and/or second-line medicines as a result of the associated problems caused by the underlying disease.
If you recognise yourself in the above, you belong to the highly immunocompromised group. At this stage, you should avoid any possibility of exposure to infection because you are using anti-inflammatory medicines and/or cytostatic drugs.
Passage not translated: Source passage not translated pending clarification: a sentence linking vaccine effectiveness to stopping corticosteroids. No replacement instruction has been added.
Your immunologist must assess whether interrupting treatment poses a risk.
Passage not translated: Source passage not translated pending clarification: a sentence specifying a corticosteroid dose threshold. No replacement instruction has been added.
Studies say that, after long-term use of corticosteroids, the immune system can take up to three months to recover.
Cytostatic drugs
Passage not translated: Source passage not translated pending clarification: a sentence specifying a methotrexate break around vaccination. No replacement instruction has been added.
In any case, it is better not to interrupt treatment unless it is necessary.
Influenza vaccine
These are safe vaccines that have been studied and are recommended for people with autoimmune diseases who are not in the acute phase.
Studies have shown that influenza vaccination leads to short-term changes in inflammatory activity, as indicated by increased circulating concentrations of IL-6 and C-reactive protein and increased expression of inflammation-related genes.
People who are not in the acute phase and are not taking medicines to suppress the immune system are nevertheless recommended to use preventive vaccines, of course on the recommendation of the doctor monitoring the course of their disease.
Vaccines against coronavirus
In a few cases, research has identified an association between vaccination and the "unmasking" of sarcoidosis, raising concern about the relationship between vaccination and the immediate onset of an acute state of the disease.
Triggering an immune response to a vaccine is not the cause of sarcoidosis. The cause is a genetic predisposition (the BTNL2 gene, a costimulatory molecule from the B7 family associated with sarcoidosis, has been identified on chromosome 6), rather than the vaccine. Nevertheless, against such a genetic background, the vaccine triggered an acute outbreak of the disease in the form of Löfgren's syndrome in a certain number of patients.
Passage not translated: Source passage not translated pending clarification: a sentence attributing a general vaccination recommendation to Pfizer without citing a source. No replacement instruction has been added.
In the event of a viral infection, it is best to consult a doctor.
Passage not translated: Source passage not translated pending clarification: a sentence about interrupting cytostatic treatment and associated measures during a viral illness. No replacement instruction has been added.
Passage not translated: Source passage not translated pending clarification: a sentence about adding antiplatelet medicines for COVID-19. No replacement instruction has been added.
Conclusion:
Before vaccination against seasonal viral infections, always consult your specialist doctor because of possible contraindications.
Dino-Josip Ključarić